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SUMMARY
The objectives of this study were to determine both the prevalence of microsporidial intestinal infection and the clinical outcome
of the disease in a cohort of 40 HIV-infected patients presenting with chronic diarrhea in Rio de Janeiro, Brazil. Each patient, after
clinical evaluation, had stools and intestinal fragments examined for viral, bacterial and parasitic pathogens. Microsporidia were
found in 11 patients (27.5%) either in stools or in duodenal or ileal biopsies. Microsporidial spores were found more frequently in
stools than in biopsy fragments. Samples examined using transmission electron microscopy (n=3) or polymerase chain reaction (n=6)
confirmed Enterocytozoon bieneusi as the causative agent. Microsporidia were the only potential enteric pathogens found in 5 of the
11 patients. Other pathogens were also detected in the intestinal tract of 21 patients, but diarrhea remained unexplained in 8. We
concluded that microsporidial infection is frequently found in HIV infected persons in Rio de Janeiro, and it seems to be a marker of
advanced stage of AIDS.
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INTRODUCTION
Diarrhea is a common clinical manifestation of human
immunodeficiency virus (HIV-1) infection both in developing and
developed countries8,20,33. In temperate and in tropical countries chronic
diarrhea associated with significant weight loss is often the presenting
illness of HIV-1 infected individuals25. Prospective studies of chronic
diarrhea in patients with AIDS suggest that identifiable enteric pathogens
account for 75-85% of cases2,8,20,23,33. Among the emerging and
opportunistic enteric agents, microsporidia have gained attention in the
past few years. Over 1000 cases of microsporidiosis have been
documented all over the world, with the majority attributed to
Enterocytozoon bieneusi8,38. Several clinical and epidemiological studies
indicated that E. bieneusi infection is associated with intestinal and biliary
illness and it is present in 7 to 60% of persons infected with HIV having
CD4 cell counts below 100/mm3 8,38. More recently, microsporidiosis
has been identified in HIV-infected patients with relatively preserved
CD4 levels, as well as in persons with AIDS without diarrhea8,31,35. There
is only scant information available on the prevalence of microsporidiosis
in South America1,5,36,40. In Brazil, there are few reports of microsporidial
infection and the prevalence of intestinal microsporidiosis in patients
with unexplained chronic diarrhea is largely unknown5,41. A pilot study
conducted in Rio de Janeiro showed that up to 46% of AIDS patients
with chronic diarrhea were infected by microsporidia, suggesting that
these parasites may be potentially significant pathogens in Brazil7. In
the present study, we describe a cross-sectional study of enteric infection
in 40 AIDS patients in Rio de Janeiro, to ascertain the prevalence of
intestinal infection either in the presence of microsporidia alone, or in
the presence of microsporidia associated with other known intestinal
pathogens. We have also compared the clinical features of patients with
chronic diarrhea infected with microsporidia, with those patients infected
with other enteric parasites.
MATERIALS AND METHODS
Patients: Forty HIV-infected patients with chronic diarrhea were
recruited from the Infectious Diseases Clinics, Hospital Universitário
Pedro Ernesto-HUPE (a large tertiary care facility that belongs to the
State University of Rio de Janeiro), on a voluntary basis to participate in
the present study, designed to investigate the cause of their diarrhea and
possible microorganisms associations with microsporidia. Chronic
diarrhea was defined as continuous (at least two episodes of loose to
watery bowel movements per day, persisting for at least 1 month) or
intermittent (defined as episodes of two or more loose stools per day,
alternating with episodes of formed stools, for more than one month)24.
All patients had symptomatic HIV disease as determined by CDC11: C3
(n=32), C2 (n=1), B3 (n=6), and B2 (n=1). The wasting syndrome
associated with diarrheal illness was the AIDS-defining illness in eighteen
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(45%) of the 40 patients. In the remaining 22 (65%) patients, the AIDS
defining illness had occurred on average 18 +/- 16 months before the
occurrence of the diarrhea (range 0 to 72 months). Patients infected with
microsporidia who survived were followed for at least one year after the
first visit of the patient to the clinic.
The study protocol was approved by the ethics review board of
HUPE. Informed consent was obtained from each patient prior entering
the study after detailed information provided.
Clinical and Laboratory evaluation: Complete medical histories
and physical examinations with regular weight of the patients were
conducted for all study participants. Blood samples were processed for
whole blood cells and CD4 counts, within one month of recruitment.
Detection of intestinal pathogens in stools: Each patient had at
least three consecutive stool samples examined by standard culture for
detection of bacteria, including Salmonella, Shigella, Campylobacter
and Aeromonas. At least three other consecutive stool specimens were
evaluated for larvae, ova and parasites. Additional methods included
either acid-fast or safranin-methylene blue for Coccidia3,7.
Detection of microsporidia spores was accomplished after processing
stool samples in thin smears using the modified chromotrope stain along
with the recently described Gram-chromotrope staining method27,28,37.
The criteria used to define microsporidia-positive patients was the
presence of one or more pinkish (chromotrope) or pinkish-violet (Gram-
chromotrope) ovoid structures with a spore wall and a belt-like stripe,
over an examination of at least 100 field /100x, confirmed by 2 examiners.
Patients who tested positive for microsporidial spores in stools were
asked to have their stools examined at least every other month during
the 24 month follow-up.
Detection of intestinal pathogens in biopsy specimens: Thirty-nine
out of the enrolled 40 patients underwent fiber-optic upper gastrointestinal
endoscopy or colonoscopy. Seven random samples per patient were taken
from each area of duodenum, ileum and colon. Each specimen was fixed
in 10% formalin and embedded in paraffin. Tissue sections (4µm) were
stained using different methods including hematoxylin-eosin, Grocott’s
methenamine silver, Giemsa, Fite and were examined using light
microscopy (LM) (400X and 1000X). The pathologists reading the biopsy
specimens were blinded to the results of the stool examination. Additionally,
for three microsporidia-positive patients, biopsy specimens were fixed in
glutaraldehyde and embedded in epon resin for examination using
transmission electron microscopy (TEM).
Detection of microsporidia by PCR: DNA was extracted from 6
stool samples out of the 11 that were positive for microsporidia by first
disrupting the sample with silanized glass beads in the presence of a
digestion buffer containing EDTA and lauryl alcohol polyether and
subsequent digestion with proteinase K. The resulting extract was purified
on a MicroSpin Ion-Exchange column, available in the RapidPrep
Genomic DNA isolation kit for cells and tissues (Pharmacia Biotech)13.
PCR amplification was performed with primer pairs EBIEF1/EBIER1
and SINTF1/SINTR14,15. These amplify diagnostic fragments of 607 bp
and 520 bp of E. bieneusi and Encephalitozoon intestinalis SSU-rRNA
coding region respectively. Conditions for all PCR reactions were
denaturation at 94 °C for 30 s, annealing at 55 °C (45 °C for SINTF1/
SINTR) for 30 s, and extension at 72 °C for 90 s in a GenAmp 2400
PCR machine (Perkin-Elmer Cetus).
PCR of stool was chosen as a confirmatory method of direct stool
examination when biopsy was not available.
Statistical analysis: Statistical analysis was applied for comparison
of clinical and biological features of patients with and without
microsporidiosis. It was performed using chi square tests for categorical
variables and the nonparametric Kruskal Wallis test, for continuous
variables. A p<0.05 was considered as statistically significant26.
RESULTS
Prevalence of intestinal pathogens: Stool examinations and studies of
duodenoileal and colonic tissues revealed pathogens in 32 (80%) out of 40
patients. Eleven patients (27.5%; 95% confidence interval, 14-41) had
microsporidiosis diagnosed by stool examination and confirmed either by
examination of intestinal biopsy or by PCR with DNA extracted from stools.
Microsporidia were the second most frequent cause of intestinal infection
after Cryptosporidium (thirteen cases - 32.5%) and was the only potential
enteric pathogen in five patients (13%; 95% confidence interval, 3-23).
Cytomegalovirus (CMV) was the third agent found in these cases (n=9 -
22.5%). The cause of diarrhea was not identified in 8 patients (Table 1).
Endoscopic findings: No mucosal lesion was observed at
esophagogastroduodenoscopy or ileonoscopy of patients infected solely
with microsporidia. The mucosa appeared grossly normal in all but 2
patients, who were co-infected with Cryptosporidium. Patients presented
a hyperemic duodenal mucosa covered by a white thick exsudate.
Morphologic detection of microsporidia
Light microscopy of stool samples: Microsporidial spores were
found in the stools of all 11 patients by the Chromotrope and Gram-
chromotrope staining methods. The spores were found more easily with
the second method, although no measurable difference of sensitivity
could be made between them (Fig. 1A, 1B).
Biopsy Pathology: Microsporidia were found in eight of the 39
patients for whom biopsy was accomplished (20.5%; 95% confidence
interval, 8-33). No microsporidial spore was seen after histopathological
examination of two patients who excreted spores in stools; microsporidia
was confirmed as the only potential enteric pathogen in five (45%) of 11
infected patients (Table 1). Duodenal or terminal ileum biopsy samples
showed the same parasite load.
Biopsies from duodenum and ileum revealed spores inside the
cytoplasm of epithelial cells, most of them in a supranuclear location on
the luminal side, and some distributed in the cytoplasm of the epithelial
cells. Infected enterocytes that were filled with spores appeared
degenerated. Clusters of microsporidial spores and sloughed off cells
were also seen free in the lamina propria and in the intestinal lumen.
Mild to severe villous atrophy were also evident. Expansion of the lamina
propria by an infiltrate of lymphocytes, plasma cells, increased apoptotic
debris, macrophages and eosinophils were also evident, but neutrophils
were rarely seen. There was no evidence of active enteritis, crypt
abscesses, or ulceration associated with these cases.
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Table 1
Diagnosis, clinical and biological features of 11 microsporidia infected patients with AIDS in Rio de Janeiro, Brazil
Patient Stools Stools Intestinal Microsporidia Other pathogens Cachexia CD4 count Survival time
(LM*) (PCR) biopsy species in stool or after diagnosis of
 (LM) biopsy specimens (cells/mm3) microsporidiosis
(months)
1 P ND§ P U None detected No 8 8
2 P ND P E.bieneusi# None detected No 22 24
3 P ND P U None detected Yes 49 24
4 P ND P U None detected Yes 10 <1
5 P ND P U Cryptosp. Yes 85 2
6 P P P E.bieneusi# None detected No 38 7
7 P P ND** E.bieneusi U Yes 6 <1
8 P P P E.bieneusi CMV+ Cryptosp. Yes 14 3
9 P P N E.bieneusi CMV Yes 15 8
10 P P P E.bieneusi# Cryptosp. Yes 12 3
11 P P N E.bieneusi CMV Yes 7 3
*LM: light microscopy; §ND: not done; # identified using transmission electron microscopy (TEM); **Patient died 3 days after microsporidial spores were
detected in his stools; P: positive; N: negative; U: unknown; Cryptosp.: Cryptosporidium; CMV: Cytomegalovirus
Microsporidial species identification
TEM: Characteristics of spores were confirmed in three patients by
electron microscopy after ultrastructural examination of duodenal biopsy
specimens. Spores with an electron-lucent endospore, a thin electron-
dense exospore and a polar filament with 6 overlapping coils which
appeared in cross-section as a series of three doublets features were
compatible with E. bieneusi. Septata-like spores and plasmodia were
not found in the studied samples.
PCR amplification: PCR was performed in the stools of six of the
eleven patients who tested positive for microsporidia by light microscopy,
as PCR for microsporidia was not available in our laboratory in the
beginning of the work. All samples tested were confirmed as positive
for E. bieneusi using the primers EBIEF1/EBIER1. There was no positive
reaction with the E. intestinalis diagnostic primers (Fig. 2).
Clinical and biological features of patients with microsporidiosis:
Upon enrollment, the mean age of microsporidian infected patients (9
men and 2 women) was 38 years and median age was 37 +/- 15 years.
All of them had acquired HIV infection by sexual contact. Nine patients
had AIDS. Two patients had microsporidiosis as the first illness related
to AIDS. The wasting syndrome associated with diarrheal illness was
the AIDS-defining illness in six (54.5%) of 11 patients. In the remaining
five patients (65.5%), the AIDS-defining illness had occurred a mean of
12 +/- 19 months before the diagnosis of microsporidiosis.
The clinical and biological features of patients with intestinal
microsporidiosis can be found in Table 1. Cachexia was recorded when
the patient lost more than 10% of baseline body weight, associated with
muscle atrophy. All patients were receiving antiretroviral therapy,
zidovudine (AZT) and dideoxyinosine (ddI), in addition to
sulphamethoxazole-trimethoprim. All patients, except one, had
intermittent diarrhea and eight of them were followed after initiating
specific treatment with albendazole (400 mg twice daily for 4 weeks),
which seemed not to alter the frequency of the diarrhea.
Duration of follow-up ranged from 1 to 24 months, with a mean of 6
Fig. 1 - Microsporidia spores in stool smears stained by the
Gram-chromotrope method. 1,250X. At the moment of
diagnosis, many spores could be seen (A). During treatment
with albendazole a few spores were seen (B).
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when microsporidia was the only pathogen or when it was associated
with others. The wasting syndrome with chronic diarrhea as the AIDS
defining illness was more frequent in the microsporidia infected group.
Patients with microsporidiosis had more advanced HIV disease, as
demonstrated by a significantly lower CD4 cell count, although this was
not evident when the total lymphocyte count were used as a marker. All
patients with microsporidiosis had CD4 counts <85/mm3. Patients without
microsporidiosis had a better prognosis: only 8 of 27 patients from this
group died, compared to 9 of 11 patients from the microsporidia-infected
group, during the follow-up.
DISCUSSION
This study examined 40 AIDS patients, over a 24-month period.
The total patients studied represented 67% of all patients with chronic
diarrhea seen in a specialized center in Rio de Janeiro. We found an 80%
prevalence of identifiable enteric pathogens, similar to studies by other
investigators in developed countries20,22,23,34. Cryptosporidium and CMV,
accounted together for 55% of the diagnosed causes of chronic diarrhea,
in accordance to previous studies2,33. An etiologic agent of diarrhea was
not found in eight patients, and the finds of others suggest that HIV
infection itself may have caused the diarrhea in these patients19.
Microsporidia was found in 11 out of 40 (27.5%) patients with
chronic diarrhea, prevalence similar to others that documented a rate of
infection between 12% to 60% among HIV-infected patients with chronic
unexplained diarrhea7-9,16,17,22,29,30,34,38.
Of interest, microsporidia was found as the single agent detected in
five of 11 cases, thus providing some evidence for a causal relationship
between parasitic infection and chronic diarrhea. Also, the progressive
damage to the microvilli of infected cells, desquamation of infected
enterocytes at rapid rate are strong evidence for a causal relation between
this parasite and gastrointestinal disease, as already observed by
others4,16,21,30,32,39.
LM or TEM examination of tissue has been considered as the gold
standard to the diagnosis of microsporidial infection38. However, in this
study, detection of microsporidia in stools using either chromotrope
Table 2
Clinical and biological features of HIV-infected patients with chronic diarrhea with and without microsporidiosis in Rio de Janeiro, R.J., Brazil
Microsporidia Microsporidia Other Unexplained P
alone# associated pathogens diarrhea
(n=5) (n=5)  (n=21) (n=8)
Age * 37 35 31 42 0.20
Gender (male/female ratio) 4/1 4/1 21/0 8/0
Weight loss(kg) kg 11 12 7 5.5 0.01*
Cachexia 2 5 6 1 0.009*
AIDS indicator conditions 5 5 20 7 0.63
Diarrhea as AIDS defining syndrome 2 5 6 5 0.02
Survival after one year 2 0 13 6 0.041*
Leucocytes 3950 2600 3250 3150 0.82
Lymphocytes 780 865 784 600 0.84
CD4 cells/mm3 22 14 25 80 0.013*
#One patient, who died a few days after E.bieneusi spores were found in his stools, was excluded from this analysis because he was not fully evaluated; kg Median
of weight loss during the period of diarrhea; * Data for the continuous variables are their median values (p<0.05)*
Fig. 2 - Agarose gel analysis of PCR-amplified products using species-specific primers for
Enterocytozoon bieneusi (EBIEF1/EBIER1, lanes 1 to 8) and Encephalitozoon (sin. Septata)
intestinalis (SINTF1/SINTR, lanes 9 to 16). Lanes 1 to 6: DNA purified from stool samples
amplified using primers EBIEF1/EBIER1. Lanes 9 to 14: DNA purified from stool samples,
amplified using primers SINTF1/SINTR. Lane 7: Enterocytozoon bieneusi cloned SSU-rRNA
region used as positive control. Lane 15: Encephalitozoon (sin.Septata) intestinalis cloned
SSU-rRNA region used as positive control. Lanes 8 and 16, DNA extracted from human lung
fibroblast cells used as negative control. Lane S contains the 100-bp ladder standard. Numbers
to the left of the gel indicate the DNA diagnostic fragment in base pairs for E. bieneusi, and
to the right, for E. intestinalis.
months. Nine patients died after the diagnosis of microsporidia infection, 2
of them died immediately after enrollment, and 1 died two months later.
The mean survival time was 4 months (range 1-8 months) after the diagnosis.
A comparison of clinical and biological features of patients with
and without microsporidiosis can be found in Table 2. In summary, mean
ages were similar for both groups. Weight loss and cachexia were
significantly more important in patients with microsporidiosis, either
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staining, or the new gram-chromotrope were sufficient to establish a
diagnosis27,37. Besides reducing the necessity of invasive procedures, it
has special interest in developing countries such as Brazil, since the
costs of more sophisticated methods like biopsy or PCR were reduced
as well.
Microsporidia were found in duodenal as well as in ileal tissue.
Colonoscopy with ileal biopsy may remain as an important diagnostic
tool because it allows for the detection of cytomegalovirus colitis, which
happened to be our third most diagnosed enteric infection. Additionally,
the ileal biopsy was useful for the detection of microsporidia, among
other small bowel infectious agents that could be susceptible to medical
therapy.
Examination of small bowel tissue by LM, using the traditional
staining methods (HE, Brown-Brenn, Giemsa) was less sensitive in this
study. Our negative findings using these methods in specimens from
two patients in whom microsporidia spores were detected in stool samples
using either light microscopy or PCR, suggests that tissue examination
using LM may also fail to detect microsporidia in small-bowel tissue.
The variable sensitivity of LM may be due to the focal distribution of
infected enterocytes, the selected biopsy site, the small amount of tissue
obtained with biopsies or the lack of utilization of Warthin-Starry or
Gram-chromothrope, more specific stainning for microsporidia in
tissues17,28,37.
PCR amplification using diagnostic primers for identification of E.
bieneusi and E. intestinalis designed on the SSU-rRNA coding region,
useful for species identification, have important treatment implications,
since diarrhea by E. intestinalis respond to albendazole therapy. It has
been reported that E. intestinalis is responsible for 1% to 10% of
microsporidial intestinal infections8,17. Nevertheless, in our study, E.
bieneusi was the only species identified among our patients, probably
because of the small number of microsporidia-infected patients studied
and the limited number of samples analyzed for species determination
(seven out of eleven). This result may also explain the lack of effectiveness
of albendazole therapy in the outcome of the diarrhea of our patients.
Analysis of the present data obtained for the 40 AIDS patients with
chronic diarrhea revealed that the presence of microsporidia parasites might
lead to a debilitating diarrhea, with an important weight loss, resulting in
cachexia, which may be a significant cause or cofactor in the death of
many patients. Whether or not the onset of AIDS with diarrhea is a predictor
of microsporidia infection, as suggested by our data, needs further
evaluation. Additionally, the decreased survival of microsporidia-infected
patients was well correlated with the lowest CD4 cell counts. Intestinal
microsporidiosis seems to be a marker of advanced stage of AIDS.
The intermittent characteristic of the diarrhea observed in all but
one patient could be related to the partial restoration of immunity to E.
bieneusi by the combination of nucleoside-analogues utilized by all
patients. Complete resolution of diarrhea, as observed with the use of
antiretroviral combinations with protease inhibitors, could not be
evaluated since these drugs were not available during the current
study5,6,10,12,18,29.
Improved diagnosis of microsporidia in stool samples might result
in an increase in the detection of microsporidial spores in AIDS patients
in Brazil and other developing countries as well. Microsporidia seems
to be an important agent of chronic diarrhea among AIDS patients in
Brazil and further studies are warranted.
RESUMO
Aspectos clínicos e diagnósticos da microsporidiose intestinal
em pacientes com infecção pelo HIV e diarréia crônica,
no Rio de Janeiro, Brasil
Os objetivos deste estudo foram determinar a prevalência e o
prognóstico clínico da infecção por microsporídios em uma coorte de
40 pacientes com infecção pelo HIV e diarréia crônica na cidade do Rio
de Janeiro, Brasil. Cada paciente teve suas fezes e fragmentos de intestino
examinados para a pesquisa de CMV, bactérias e parasitos.
A prevalência de microsporidiose foi de 27,5% (n=11). Esporos de
microsporídios foram encontrados com maior frequência no exame direto
das fezes do que em biópsias de intestino delgado. A microscopia
eletrônica de transmissão e a reação de polimerase em cadeia (PCR)
identificaram Enterocytozoon bieneusi, respectivamente, em 3 e 6
amostras examinadas, confirmando a espécie como único agente causal.
Nenhum outro microrganismo patogênico, além dos microsporídios, foi
detectada em 5 dos pacientes com diarréia. Outros parasitos foram
encontrados no trato digestivo de 21 pacientes, enquanto que em 8 a
etiologia da diarréia não foi definida. Concluímos que a infecção por
microsporídios pode ser freqüentemente encontrada em indivíduos
infectados pelo HIV no Rio de Janeiro.
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